Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine in combat-related PTSD
NCT00700999Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 2008
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of paroxetine in post-traumatic stress disorder (PTSD), sponsored by United States Department of Veterans Affairs. Primary endpoint: Percent Change in Brain Response Measured by Functional Magnetic Resonance Imaging at 12 weeks. Started Oct 2008; status: completed.
02
Drugs
paroxetine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00700999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700999.